Patent · US Active

GPR120 receptor agonists and uses thereof

US8476308B2 · kind B2 · utility

12Cited by

8References

6Claims

0Family size

Assignee

Metabolex, Inc. · US

Inventors

Dong-Fang Shi · Fremont, US
Jiangao Song · Cupertino, US
Jingyuan Ma · Sunnyvale, US
Aaron Novack · San Jose, US
Phuongly Pham · Hayward, US
Imad Nashashibi · San Jose, US
Christopher J. Rabbat · San Jose, US
Xin Chen · Lexington, US

Key dates

Filing date	Oct 4, 2012
Grant date	Jul 2, 2013
Priority date	—
Expiry date	Oct 4, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.